Click for best price
Artemisinin Antimalarial Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Artemisinin Antimalarial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinin Antimalarial Drugs. This report contains market size and forecasts of Artemisinin Antimalarial Drugs in global, including the following market information:
Global Artemisinin Antimalarial Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Artemisinin Antimalarial Drugs Market Sales, 2018-2023, 2024-2032, (KG)
Global top five Artemisinin Antimalarial Drugs companies in 2022 (%)
The global Artemisinin Antimalarial Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Artesunate Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Artemisinin Antimalarial Drugs include Novartis, Sanofi, Ajanta, Cipla, Ipca, Guilin Medicine, GlaxoSmithKline, Mylan Labs and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Artemisinin Antimalarial Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artemisinin Antimalarial Drugs Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (KG)
Global Artemisinin Antimalarial Drugs Market Segment Percentages, by Type, 2022 (%)
Artesunate
Dihydroartemisinin
Artemether
Global Artemisinin Antimalarial Drugs Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (KG)
Global Artemisinin Antimalarial Drugs Market Segment Percentages, by Application, 2022 (%)
Prevention
Treatment
Other
Global Artemisinin Antimalarial Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (KG)
Global Artemisinin Antimalarial Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artemisinin Antimalarial Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Artemisinin Antimalarial Drugs revenues share in global market, 2022 (%)
Key companies Artemisinin Antimalarial Drugs sales in global market, 2018-2023 (Estimated), (KG)
Key companies Artemisinin Antimalarial Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Sanofi
Ajanta
Cipla
Ipca
Guilin Medicine
GlaxoSmithKline
Mylan Labs
Roche
Outline of Major Chapters:
Chapter 1: Introduces the definition of Artemisinin Antimalarial Drugs, market overview.
Chapter 2: Global Artemisinin Antimalarial Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Artemisinin Antimalarial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Artemisinin Antimalarial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Artemisinin Antimalarial Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Artemisinin Antimalarial Drugs Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
76 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Artemisinin Antimalarial Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Artemisinin Antimalarial Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artemisinin Antimalarial Drugs Overall Market Size
2.1 Global Artemisinin Antimalarial Drugs Market Size: 2022 VS 2032
2.2 Global Artemisinin Antimalarial Drugs Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Artemisinin Antimalarial Drugs Sales: 2018-2032
3 Company Landscape
3.1 Top Artemisinin Antimalarial Drugs Players in Global Market
3.2 Top Global Artemisinin Antimalarial Drugs Companies Ranked by Revenue
3.3 Global Artemisinin Antimalarial Drugs Revenue by Companies
3.4 Global Artemisinin Antimalarial Drugs Sales by Companies
3.5 Global Artemisinin Antimalarial Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Artemisinin Antimalarial Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Artemisinin Antimalarial Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Artemisinin Antimalarial Drugs Players in Global Market
3.8.1 List of Global Tier 1 Artemisinin Antimalarial Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Artemisinin Antimalarial Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Artemisinin Antimalarial Drugs Market Size Markets, 2022 & 2032
4.1.2 Artesunate
4.1.3 Dihydroartemisinin
4.1.4 Artemether
4.2 By Type - Global Artemisinin Antimalarial Drugs Revenue & Forecasts
4.2.1 By Type - Global Artemisinin Antimalarial Drugs Revenue, 2018-2023
4.2.2 By Type - Global Artemisinin Antimalarial Drugs Revenue, 2024-2032
4.2.3 By Type - Global Artemisinin Antimalarial Drugs Revenue Market Share, 2018-2032
4.3 By Type - Global Artemisinin Antimalarial Drugs Sales & Forecasts
4.3.1 By Type - Global Artemisinin Antimalarial Drugs Sales, 2018-2023
4.3.2 By Type - Global Artemisinin Antimalarial Drugs Sales, 2024-2032
4.3.3 By Type - Global Artemisinin Antimalarial Drugs Sales Market Share, 2018-2032
4.4 By Type - Global Artemisinin Antimalarial Drugs Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Artemisinin Antimalarial Drugs Market Size, 2022 & 2032
5.1.2 Prevention
5.1.3 Treatment
5.1.4 Other
5.2 By Application - Global Artemisinin Antimalarial Drugs Revenue & Forecasts
5.2.1 By Application - Global Artemisinin Antimalarial Drugs Revenue, 2018-2023
5.2.2 By Application - Global Artemisinin Antimalarial Drugs Revenue, 2024-2032
5.2.3 By Application - Global Artemisinin Antimalarial Drugs Revenue Market Share, 2018-2032
5.3 By Application - Global Artemisinin Antimalarial Drugs Sales & Forecasts
5.3.1 By Application - Global Artemisinin Antimalarial Drugs Sales, 2018-2023
5.3.2 By Application - Global Artemisinin Antimalarial Drugs Sales, 2024-2032
5.3.3 By Application - Global Artemisinin Antimalarial Drugs Sales Market Share, 2018-2032
5.4 By Application - Global Artemisinin Antimalarial Drugs Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Artemisinin Antimalarial Drugs Market Size, 2022 & 2032
6.2 By Region - Global Artemisinin Antimalarial Drugs Revenue & Forecasts
6.2.1 By Region - Global Artemisinin Antimalarial Drugs Revenue, 2018-2023
6.2.2 By Region - Global Artemisinin Antimalarial Drugs Revenue, 2024-2032
6.2.3 By Region - Global Artemisinin Antimalarial Drugs Revenue Market Share, 2018-2032
6.3 By Region - Global Artemisinin Antimalarial Drugs Sales & Forecasts
6.3.1 By Region - Global Artemisinin Antimalarial Drugs Sales, 2018-2023
6.3.2 By Region - Global Artemisinin Antimalarial Drugs Sales, 2024-2032
6.3.3 By Region - Global Artemisinin Antimalarial Drugs Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Artemisinin Antimalarial Drugs Revenue, 2018-2032
6.4.2 By Country - North America Artemisinin Antimalarial Drugs Sales, 2018-2032
6.4.3 US Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.4.4 Canada Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.4.5 Mexico Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Artemisinin Antimalarial Drugs Revenue, 2018-2032
6.5.2 By Country - Europe Artemisinin Antimalarial Drugs Sales, 2018-2032
6.5.3 Germany Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.5.4 France Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.5.5 U.K. Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.5.6 Italy Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.5.7 Russia Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.5.8 Nordic Countries Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.5.9 Benelux Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Artemisinin Antimalarial Drugs Revenue, 2018-2032
6.6.2 By Region - Asia Artemisinin Antimalarial Drugs Sales, 2018-2032
6.6.3 China Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.6.4 Japan Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.6.5 South Korea Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.6.6 Southeast Asia Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.6.7 India Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Artemisinin Antimalarial Drugs Revenue, 2018-2032
6.7.2 By Country - South America Artemisinin Antimalarial Drugs Sales, 2018-2032
6.7.3 Brazil Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.7.4 Argentina Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Artemisinin Antimalarial Drugs Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Artemisinin Antimalarial Drugs Sales, 2018-2032
6.8.3 Turkey Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.8.4 Israel Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.8.5 Saudi Arabia Artemisinin Antimalarial Drugs Market Size, 2018-2032
6.8.6 UAE Artemisinin Antimalarial Drugs Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Artemisinin Antimalarial Drugs Major Product Offerings
7.1.4 Novartis Artemisinin Antimalarial Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Artemisinin Antimalarial Drugs Major Product Offerings
7.2.4 Sanofi Artemisinin Antimalarial Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Ajanta
7.3.1 Ajanta Company Summary
7.3.2 Ajanta Business Overview
7.3.3 Ajanta Artemisinin Antimalarial Drugs Major Product Offerings
7.3.4 Ajanta Artemisinin Antimalarial Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Ajanta Key News & Latest Developments
7.4 Cipla
7.4.1 Cipla Company Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Artemisinin Antimalarial Drugs Major Product Offerings
7.4.4 Cipla Artemisinin Antimalarial Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Cipla Key News & Latest Developments
7.5 Ipca
7.5.1 Ipca Company Summary
7.5.2 Ipca Business Overview
7.5.3 Ipca Artemisinin Antimalarial Drugs Major Product Offerings
7.5.4 Ipca Artemisinin Antimalarial Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Ipca Key News & Latest Developments
7.6 Guilin Medicine
7.6.1 Guilin Medicine Company Summary
7.6.2 Guilin Medicine Business Overview
7.6.3 Guilin Medicine Artemisinin Antimalarial Drugs Major Product Offerings
7.6.4 Guilin Medicine Artemisinin Antimalarial Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Guilin Medicine Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Artemisinin Antimalarial Drugs Major Product Offerings
7.7.4 GlaxoSmithKline Artemisinin Antimalarial Drugs Sales and Revenue in Global (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 Mylan Labs
7.8.1 Mylan Labs Company Summary
7.8.2 Mylan Labs Business Overview
7.8.3 Mylan Labs Artemisinin Antimalarial Drugs Major Product Offerings
7.8.4 Mylan Labs Artemisinin Antimalarial Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Mylan Labs Key News & Latest Developments
7.9 Roche
7.9.1 Roche Company Summary
7.9.2 Roche Business Overview
7.9.3 Roche Artemisinin Antimalarial Drugs Major Product Offerings
7.9.4 Roche Artemisinin Antimalarial Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Roche Key News & Latest Developments
8 Global Artemisinin Antimalarial Drugs Production Capacity, Analysis
8.1 Global Artemisinin Antimalarial Drugs Production Capacity, 2018-2032
8.2 Artemisinin Antimalarial Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Artemisinin Antimalarial Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Artemisinin Antimalarial Drugs Supply Chain Analysis
10.1 Artemisinin Antimalarial Drugs Industry Value Chain
10.2 Artemisinin Antimalarial Drugs Upstream Market
10.3 Artemisinin Antimalarial Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Artemisinin Antimalarial Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Artemisinin Antimalarial Drugs in Global Market
Table 2. Top Artemisinin Antimalarial Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Artemisinin Antimalarial Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Artemisinin Antimalarial Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Artemisinin Antimalarial Drugs Sales by Companies, (KG), 2018-2023
Table 6. Global Artemisinin Antimalarial Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Artemisinin Antimalarial Drugs Price (2018-2023) & (US$/G)
Table 8. Global Manufacturers Artemisinin Antimalarial Drugs Product Type
Table 9. List of Global Tier 1 Artemisinin Antimalarial Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Artemisinin Antimalarial Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Artemisinin Antimalarial Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Artemisinin Antimalarial Drugs Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Artemisinin Antimalarial Drugs Sales (KG), 2018-2023
Table 15. By Type - Global Artemisinin Antimalarial Drugs Sales (KG), 2024-2032
Table 16. By Application ? Global Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Artemisinin Antimalarial Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Artemisinin Antimalarial Drugs Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Artemisinin Antimalarial Drugs Sales (KG), 2018-2023
Table 20. By Application - Global Artemisinin Antimalarial Drugs Sales (KG), 2024-2032
Table 21. By Region ? Global Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Artemisinin Antimalarial Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Artemisinin Antimalarial Drugs Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Artemisinin Antimalarial Drugs Sales (KG), 2018-2023
Table 25. By Region - Global Artemisinin Antimalarial Drugs Sales (KG), 2024-2032
Table 26. By Country - North America Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Artemisinin Antimalarial Drugs Sales, (KG), 2018-2023
Table 29. By Country - North America Artemisinin Antimalarial Drugs Sales, (KG), 2024-2032
Table 30. By Country - Europe Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Artemisinin Antimalarial Drugs Sales, (KG), 2018-2023
Table 33. By Country - Europe Artemisinin Antimalarial Drugs Sales, (KG), 2024-2032
Table 34. By Region - Asia Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Artemisinin Antimalarial Drugs Sales, (KG), 2018-2023
Table 37. By Region - Asia Artemisinin Antimalarial Drugs Sales, (KG), 2024-2032
Table 38. By Country - South America Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Artemisinin Antimalarial Drugs Sales, (KG), 2018-2023
Table 41. By Country - South America Artemisinin Antimalarial Drugs Sales, (KG), 2024-2032
Table 42. By Country - Middle East & Africa Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Artemisinin Antimalarial Drugs Sales, (KG), 2018-2023
Table 45. By Country - Middle East & Africa Artemisinin Antimalarial Drugs Sales, (KG), 2024-2032
Table 46. Novartis Company Summary
Table 47. Novartis Artemisinin Antimalarial Drugs Product Offerings
Table 48. Novartis Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Artemisinin Antimalarial Drugs Product Offerings
Table 52. Sanofi Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Ajanta Company Summary
Table 55. Ajanta Artemisinin Antimalarial Drugs Product Offerings
Table 56. Ajanta Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 57. Ajanta Key News & Latest Developments
Table 58. Cipla Company Summary
Table 59. Cipla Artemisinin Antimalarial Drugs Product Offerings
Table 60. Cipla Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 61. Cipla Key News & Latest Developments
Table 62. Ipca Company Summary
Table 63. Ipca Artemisinin Antimalarial Drugs Product Offerings
Table 64. Ipca Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 65. Ipca Key News & Latest Developments
Table 66. Guilin Medicine Company Summary
Table 67. Guilin Medicine Artemisinin Antimalarial Drugs Product Offerings
Table 68. Guilin Medicine Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 69. Guilin Medicine Key News & Latest Developments
Table 70. GlaxoSmithKline Company Summary
Table 71. GlaxoSmithKline Artemisinin Antimalarial Drugs Product Offerings
Table 72. GlaxoSmithKline Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 73. GlaxoSmithKline Key News & Latest Developments
Table 74. Mylan Labs Company Summary
Table 75. Mylan Labs Artemisinin Antimalarial Drugs Product Offerings
Table 76. Mylan Labs Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 77. Mylan Labs Key News & Latest Developments
Table 78. Roche Company Summary
Table 79. Roche Artemisinin Antimalarial Drugs Product Offerings
Table 80. Roche Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 81. Roche Key News & Latest Developments
Table 82. Artemisinin Antimalarial Drugs Production Capacity (KG) of Key Manufacturers in Global Market, 2021-2023 (KG)
Table 83. Global Artemisinin Antimalarial Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Artemisinin Antimalarial Drugs Production by Region, 2018-2023 (KG)
Table 85. Global Artemisinin Antimalarial Drugs Production by Region, 2024-2032 (KG)
Table 86. Artemisinin Antimalarial Drugs Market Opportunities & Trends in Global Market
Table 87. Artemisinin Antimalarial Drugs Market Drivers in Global Market
Table 88. Artemisinin Antimalarial Drugs Market Restraints in Global Market
Table 89. Artemisinin Antimalarial Drugs Raw Materials
Table 90. Artemisinin Antimalarial Drugs Raw Materials Suppliers in Global Market
Table 91. Typical Artemisinin Antimalarial Drugs Downstream
Table 92. Artemisinin Antimalarial Drugs Downstream Clients in Global Market
Table 93. Artemisinin Antimalarial Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Artemisinin Antimalarial Drugs Segment by Type in 2022
Figure 2. Artemisinin Antimalarial Drugs Segment by Application in 2022
Figure 3. Global Artemisinin Antimalarial Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Artemisinin Antimalarial Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Artemisinin Antimalarial Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. Artemisinin Antimalarial Drugs Sales in Global Market: 2018-2032 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Artemisinin Antimalarial Drugs Revenue in 2022
Figure 9. By Type - Global Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Artemisinin Antimalarial Drugs Revenue Market Share, 2018-2032
Figure 11. By Type - Global Artemisinin Antimalarial Drugs Sales Market Share, 2018-2032
Figure 12. By Type - Global Artemisinin Antimalarial Drugs Price (US$/G), 2018-2032
Figure 13. By Application - Global Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Artemisinin Antimalarial Drugs Revenue Market Share, 2018-2032
Figure 15. By Application - Global Artemisinin Antimalarial Drugs Sales Market Share, 2018-2032
Figure 16. By Application - Global Artemisinin Antimalarial Drugs Price (US$/G), 2018-2032
Figure 17. By Region - Global Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Artemisinin Antimalarial Drugs Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Artemisinin Antimalarial Drugs Revenue Market Share, 2018-2032
Figure 20. By Region - Global Artemisinin Antimalarial Drugs Sales Market Share, 2018-2032
Figure 21. By Country - North America Artemisinin Antimalarial Drugs Revenue Market Share, 2018-2032
Figure 22. By Country - North America Artemisinin Antimalarial Drugs Sales Market Share, 2018-2032
Figure 23. US Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Artemisinin Antimalarial Drugs Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Artemisinin Antimalarial Drugs Sales Market Share, 2018-2032
Figure 28. Germany Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. France Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Artemisinin Antimalarial Drugs Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Artemisinin Antimalarial Drugs Sales Market Share, 2018-2032
Figure 37. China Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. India Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Artemisinin Antimalarial Drugs Revenue Market Share, 2018-2032
Figure 43. By Country - South America Artemisinin Antimalarial Drugs Sales Market Share, 2018-2032
Figure 44. Brazil Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Artemisinin Antimalarial Drugs Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share, 2018-2032
Figure 48. Turkey Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Artemisinin Antimalarial Drugs Revenue, (US$, Mn), 2018-2032
Figure 52. Global Artemisinin Antimalarial Drugs Production Capacity (KG), 2018-2032
Figure 53. The Percentage of Production Artemisinin Antimalarial Drugs by Region, 2022 VS 2032
Figure 54. Artemisinin Antimalarial Drugs Industry Value Chain
Figure 55. Marketing Channels
